Search

Novocure Ltd

Lezárt

SzektorEgészségügy

16.92 -2.48

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

16.64

Maximum

17.36

Fő mutatók

By Trading Economics

Bevétel

55M

-16M

Értékesítés

9.5M

184M

Egy részvényre jutó nyereség

-0.13

Profit margin

-8.529

Munkavállalók

1,605

EBITDA

53M

-11M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+74.04% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. okt. 29.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

169M

2B

Előző nyitás

19.4

Előző zárás

16.92

Hangulat hírek alapján

By Acuity

55%

45%

281 / 340 Rangsor szerint Healthcare

Novocure Ltd Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 14. 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

2026. aug. 13. 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

2026. aug. 12. 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

2026. aug. 11. 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

2026. aug. 10. 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

2026. aug. 8. 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

2026. aug. 7. 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

2026. aug. 6. 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

2026. aug. 5. 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

2026. aug. 4. 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

2026. aug. 3. 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

2026. júl. 31. 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

2026. júl. 30. 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

2026. júl. 29. 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

2026. júl. 28. 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

2026. júl. 27. 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

2026. júl. 24. 19:41 UTC

News
Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

2026. júl. 22. 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

2026. júl. 20. 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Társak összehasonlítása

Árváltozás

Novocure Ltd Előrejelzés

Célár

By TipRanks

74.04% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 29.5 USD  74.04%

Magas 52 USD

Alacsony 17 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)Novocure Ltd termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

4 ratings

2

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

281 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat